Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. VRAYLAR and antidepressants may increase suicidal thoughts or actions in some children and young adults especially within the first few months of treatment or when the dose is changed. VRAYLAR is not approved for treating patients with dementia-related psychosis. What is the most important information I should know about VRAYLAR?Įlderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer.įor questions about the program, including savings on mail-order prescriptions, please call 1-80.This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.The selling, purchasing, trading, or counterfeiting of this card is prohibited by law. Void if prohibited by law, taxed, or restricted.Offer good only in the USA, including Puerto Rico, at participating retail pharmacies.AbbVie reserves the right to rescind, revoke, or amend this offer without notice.The actual application and use of the benefit available under the copay assistance program may vary on a monthly, quarterly, and/or annual basis depending on each individual patient’s plan of insurance and other prescription drug costs. New patient offer only applies to 30-day prescription fills. Subject to all other terms and conditions, the maximum monthly benefit that may be available solely for the patient’s benefit under the copay assistance program is $3,250 for two 30-day prescription fills for eligible new patients, and $1,200 for a 30-day supply, $1,900 for a 60-day supply, and $3075 for a 90-day supply for existing patients.Maximum savings limit applies patient out-of-pocket expense may vary. Check with your pharmacist for your out-of-pocket discount. Eligible patients whose insurer does not cover VRAYLAR ® (cariprazine) or where coverage restrictions have not been satisfied may pay as little as $75 per 30-day supply for each of up to twelve (12) prescription fills. In these instances, eligible patients who have not previously registered for a VRAYLAR ® (cariprazine) savings card may pay as little as $0 for their first two (2) 30-day prescription fills of VRAYLAR ® (cariprazine).
0 Comments
Leave a Reply. |